BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34012147)

  • 1. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.
    Tesarikova J; Skalicky P; Kurfurstova D; Svebisova H; Urban O; Falt P; Zapletalova J; Klos D; Lovecek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):290-296. PubMed ID: 34012147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
    Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
    J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
    Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
    Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma.
    Yoshimizu S; Kawachi H; Yamamoto Y; Nakano K; Horiuchi Y; Ishiyama A; Tsuchida T; Yoshio T; Hirasawa T; Ito H; Fujisaki J
    J Gastroenterol; 2020 Aug; 55(8):754-762. PubMed ID: 32533301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Strategy for T1 Duodenal or Ampullary Carcinoma According to the Depth of Tumor Invasion.
    Kohga A; Yamamoto Y; Sano S; Sugiura T; Okamura Y; Ito T; Ashida R; Ishiwatari H; Matsubayashi H; Sasaki K; Uesaka K
    Anticancer Res; 2017 Sep; 37(9):5277-5283. PubMed ID: 28870965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.
    Sudo T; Murakami Y; Uemura K; Hayashidani Y; Hashimoto Y; Ohge H; Shimamoto F; Sueda T
    Dig Dis Sci; 2008 Aug; 53(8):2281-6. PubMed ID: 18095164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
    Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
    Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of non-ampullary duodenal adenocarcinoma.
    Hirashita T; Ohta M; Tada K; Saga K; Takayama H; Endo Y; Uchida H; Iwashita Y; Inomata M
    Jpn J Clin Oncol; 2018 Aug; 48(8):743-747. PubMed ID: 29931295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of extra-ampullary duodenal adenocarcinoma subtypes on surgical and oncological outcomes following pancreaticoduodenectomy.
    De Pastena M; Zingaretti CC; Paiella S; Guerriero M; De Santis N; Luchini C; Bassi C; Malleo G; Salvia R
    Updates Surg; 2024 Jan; 76(1):87-95. PubMed ID: 38093152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can endoscopic papillectomy be curative for early ampullary adenocarcinoma of the ampulla of Vater?
    Alvarez-Sanchez MV; Oria I; Luna OB; Pialat J; Gincul R; Lefort C; Bourdariat R; Fumex F; Lepilliez V; Scoazec JY; Salgado-Barreira A; Lemaistre AI; Napoléon B
    Surg Endosc; 2017 Apr; 31(4):1564-1572. PubMed ID: 27530895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.
    Balci S; Basturk O; Saka B; Bagci P; Postlewait LM; Tajiri T; Jang KT; Ohike N; Kim GE; Krasinskas A; Choi H; Sarmiento JM; Kooby DA; El-Rayes BF; Knight JH; Goodman M; Akkas G; Reid MD; Maithel SK; Adsay V
    Ann Surg Oncol; 2015 Dec; 22(13):4392-401. PubMed ID: 25783680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
    Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB
    J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
    Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
    World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.